Armistice Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Armistice Capital's MDT Position: Q1 2026 in Review
Armistice Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 271,241 shares — an estimated $26.1M sold.
Armistice Capital first reported a position in MDT in Q2 2020 and held it in 23 quarters. The position peaked at $73.7M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Armistice Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Armistice Capital sold 271,241 Medtronic shares in Q1 2026, an estimated $26.1M.
- Armistice Capital first reported a position in Medtronic in Q2 2020 and held it in 23 quarters.
- Armistice Capital's Medtronic position peaked at $73.7M in Q4 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.